OLMA (Olema Pharmaceuticals) Institutional Ownership: 104.11% (As of Jul. 06, 2026)


OLMA Olema Pharmaceuticals inc OLMA
28 GF Score
Price $12.76
! 2 Warning Signs
View Full Analysis

What is Olema Pharmaceuticals Institutional Ownership?

Olema Pharmaceuticals OLMA +0.95% 28 Institutional Ownership is 104.11% as of Jul. 06, 2026. GuruFocus rates OLMA with a GF Score™ of 28/100. The stock has 2 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Olema Pharmaceuticals's institutional ownership is 104.11%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Olema Pharmaceuticals's Insider Ownership is 3.88%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Olema Pharmaceuticals's Float Percentage Of Total Shares Outstanding is 82.29%.

Olema Pharmaceuticals Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Olema Pharmaceuticals's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Olema Pharmaceuticals Institutional Ownership Chart

Olema Pharmaceuticals Historical Data

The historical data trend for Olema Pharmaceuticals can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 35.88 34.26 34.19 41.64 43.32 45.80 46.36 46.41 46.88 47.81
OLMA
28GF Score
Olema Pharmaceuticals inc OLMA
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Olema Pharmaceuticals Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 104.11% mean?
Olema Pharmaceuticals (OLMA) has a Institutional Ownership of 104.11% as of Jul. 06, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Olema Pharmaceuticals and its competitors.
Is Olema Pharmaceuticals' Institutional Ownership too high?
Olema Pharmaceuticals' current Institutional Ownership is 104.11%. Overall, Olema Pharmaceuticals has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Olema Pharmaceuticals' Institutional Ownership compare to DRTS and ORIC?
Olema Pharmaceuticals' Institutional Ownership of 104.11% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Olema Pharmaceuticals and its competitors. Olema Pharmaceuticals's current Institutional Ownership is 104.11%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Olema Pharmaceuticals stock overvalued right now?
Olema Pharmaceuticals (OLMA) has a current Institutional Ownership of 104.11%. The current Institutional Ownership is 104.11%. Olema Pharmaceuticals' overall GF Score™ is 28/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Olema Pharmaceuticals (OLMA), the current Institutional Ownership is 104.11% as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Olema Pharmaceuticals Business Description

Address 780 Brannan Street, San Francisco, CA, USA, 94103
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
28GF Score

Get the complete analysis for OLMA

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.76
Price